http://www.nps.org.au/health_professionals/publications/nps_radarNPS RADARNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2012/january_2012Information about Apixaban (Eliquis), listed on the PBS from 1 January 2012 for preventing venous thromboembolism after hip or knee replacement surgery.http://www.nps.org.au/health_professionals/publications/nps_radar/2012/january_2012/brief_item_apixabanInformation about asenapine sublingual wafers (Saphris) for schizophrenia and acute and maintenance treatment of manic and mixed episodes in bipolar I disorder. Asenapine has a similar spectrum of benefits and harms to that of other antipsychotics.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/december_2011/asenapineNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/december_2011Ticagrelor (Brilinta) and aspirin reduces the incidence of vascular deaths and myocardial infarctions more than clopidogrel and aspirin, but this must be weighed against an increased risk of adverse events.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/december_2011/ticagrelorInformation about oxycodone-with-naloxone controlled-release (CR) tablets (Targin) for chronic severe pain. The tablets provide equivalent analgesia to that of oxycodone CR tablets, with reduced opioid-induced constipation.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/december_2011/oxycodone_with_naloxoneInformation on indacaterol as a once-daily, maintenance bronchodilator treatment of airflow limitation in patients with chronic obstructive pulmonary disease (COPD).http://www.nps.org.au/health_professionals/publications/nps_radar/2011/december_2011/indacaterolNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/november_2011NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/september_2011NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/august_2011NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/july_2011NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/june_2011NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/april_2011NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2011/february_2011NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/december_2010Information about denosumab, a new biological agent for the treatment of postmenopausal osteoporosis.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/december_2010/denosumabMethoxyflurane (Penthrox) article updatedhttp://www.nps.org.au/health_professionals/publications/nps_radar/2010/december_2010/brief_item_methoxyfluranePBS listings for quetiapine (Seroquel and Seroquel XR) bipolar disorder expanded 1 December 2010http://www.nps.org.au/health_professionals/publications/nps_radar/2010/december_2010/brief_item_quetiapineExenatide byetta solution for injection 5 micrograms; exenatide byetta solution for injection 10 microgramshttp://www.nps.org.au/health_professionals/publications/nps_radar/2010/november_2010/exenatideMethoxyflurane (Penthrox) 3 mL listed for emergency treatment supply (doctor’s bag) only (1 inhaler and methoxyflurane 1 x 3 mL)http://www.nps.org.au/health_professionals/publications/nps_radar/2010/may_2010/methoxyfluraneRestricted PBS listing for olmesartan with amlodipine (Sevikar), and valsartan with amlodipine and hydrochlorothiazide (Exforge HCT) effective 1 November 2010.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/november_2010/brief_item_combination_antihypertensivesTreatment now subsidised on the PBS for people receiving long-term high-dose corticosteroid therapy who have low bone mineral density.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/november_2010/brief_item_alendronateNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/november_2010NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/october_2010Eletriptan (Relpax) and other triptans for migrainehttp://www.nps.org.au/health_professionals/publications/nps_radar/2010/october_2010/brief_item_eletriptanNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/august_2010NPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/may_2010Prolonged-release melatonin may be used short-term to improve quality of sleep in people with primary insomnia aged ≥ 55 years.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/may_2010/melatoninUpdated information about dosing and drug interactions with colchicine for acute gout.http://www.nps.org.au/health_professionals/publications/nps_radar/2010/may_2010/brief_item_colchicineNew information relevant to this topic has become available since this RADAR review was published in November 2007.http://www.nps.org.au/health_professionals/publications/nps_radar/2007/november_2007/strontium/additional_information_since_publicationNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2009/december_2009Prasugrel is an alternative to clopidogrel for acute coronary syndrome managed by percutaneous coronary intervention in combination with aspirin.http://www.nps.org.au/health_professionals/publications/nps_radar/2009/december_2009/prasugrelExtension of authority listing for ciprofloxacin ear drops (Ciloxan), 1 November 2009http://www.nps.org.au/health_professionals/publications/nps_radar/2009/november_2009/brief_item_ciprofloxacinGet independent, accurate, evidence-based info on pain management drugs. Written for doctors, pharmacists & other health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/view_radar_articles_by_topic/pain_managementGet independent, accurate, evidence-based info on palliative care drugs. Written for doctors, pharmacists & other health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/view_radar_articles_by_topic/palliative_careNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2009/august_2009Information about use of Rivaroxaban (Xarelto) for preventing venous thromboembolism after hip or knee replacement surgeryhttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/august_2009/rivaroxabanInformation on use of teriparatide (Forteo) for severe osteoporosishttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/may_2009/teriparatideNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2009/may_2009Information on use of hydromorphone prolonged-release tablets (Jurnista) for chronic severe disabling painhttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/may_2009/hydromorphoneInformation on use of lanthanum (Fosrenol) tablets for adults with chronic kidney disease who are on dialysishttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/may_2009/lanthanumNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/2009/april_2009Information on use of pramipexole (Sifrol) for severe primary restless legs syndromehttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/april_2009/pramipexoleInformation on use of ziprasidone (Zeldox): another atypical antipsychotic listed for acute mania in bipolar disorderhttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/april_2009/brief_item_ziprasidoneUse of desmopressin for primary nocturnal enuresis — sublingual formulation PBS listedhttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/april_2009/brief_item_desmopressinInformation about use of desvenlafaxine (Pristiq) for major depressive disorderhttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/march_2009/desvenlafaxineInformation about use of valsartan (Diovan) and combinations with hydrochlorothiazide (Co-Diovan) or amlodipine (Exforge) in hypertensionhttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/march_2009/valsartanClopidogrel (Iscover, Plavix) PBS listing extended to include acute coronary syndrome (ACS) in combination with aspirinhttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/march_2009/brief_item_clopidogrelInformation about use of risedronate (Actonel and Actonel Once-a-Week) for corticosteroid-induced osteoporosishttp://www.nps.org.au/health_professionals/publications/nps_radar/2009/march_2009/brief_item_risedronateProvides New York Heart Association grading of heart failure (NYHA) as additional content to rosiglitazone use for type 2 diabetes mellitus.http://www.nps.org.au/health_professionals/publications/nps_radar/2008/december_2008/rosiglitazone/rosiglitazone_webextra_1Information about use of Quetiapine extended-release tablets (Seroquel XR) for schizophreniahttp://www.nps.org.au/health_professionals/publications/nps_radar/2008/december_2008/brief_item_quetiapine_xrNPS RADAR articles provide timely, independent, evidence-based assessment of new drugs, new PBS listings and research for health professionals.http://www.nps.org.au/health_professionals/publications/nps_radar/month_year